We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAMY icon
2801
United States Antimony
UAMY
$751M
$10K ﹤0.01%
25,577
AUMN
2802
DELISTED
Golden Minerals Company
AUMN
$10K ﹤0.01%
707
IMI
2803
DELISTED
Intermolecular, Inc.
IMI
$10K ﹤0.01%
10,806
MTEM
2804
DELISTED
Molecular Templates, Inc.
MTEM
$9K ﹤0.01%
138
DSS icon
2805
DSS Inc
DSS
$5.39M
$8K ﹤0.01%
18
TOVX icon
2806
Theriva Biologics
TOVX
$9.64M
$8K ﹤0.01%
2
CRTN
2807
DELISTED
Cartesian, Inc.
CRTN
$8K ﹤0.01%
10,085
BATRA icon
2808
Atlanta Braves Holdings Series A
BATRA
$3.49B
$7K ﹤0.01%
312
+7
+2% +$169
OGEN icon
2809
Oragenics
OGEN
$2.26M
$7K ﹤0.01%
1
SLS icon
2810
SELLAS Life Sciences
SLS
$1.97B
$7K ﹤0.01%
9
GMO
2811
DELISTED
General Moly, Inc.
GMO
$7K ﹤0.01%
18,108
ESNC
2812
DELISTED
EnSync Inc
ESNC
$7K ﹤0.01%
20,130
TVIA
2813
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$6K ﹤0.01%
26,961
-2,615
-9% -$945
AIM
2814
AIM ImmunoTech
AIM
$7.03M
$6K ﹤0.01%
3
ACHV icon
2815
Achieve Life Sciences
ACHV
$659M
$5K ﹤0.01%
7
VNCE icon
2816
Vince Holding Corp
VNCE
$81.3M
$5K ﹤0.01%
1,097
-71
-6% -$507
FALC
2817
DELISTED
FalconStor Software Inc
FALC
$4K ﹤0.01%
15,392
DCTH
2818
DELISTED
Delcath Systems Inc
DCTH
$4K ﹤0.01%
22,824
LGF.B
2819
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1K ﹤0.01%
45
-7,167
-99% -$174K
ACLS icon
2820
Axcelis
ACLS
$4.01B
-60,036
Closed -$1.13M
AGD
2821
abrdn Global Dynamic Dividend Fund
AGD
$318M
-22,808
Closed -$223K
ALT icon
2822
Altimmune
ALT
$552M
-52
Closed -$12K
AMPH icon
2823
Amphastar Pharmaceuticals
AMPH
$879M
-12,003
Closed -$173K
ASC icon
2824
Ardmore Shipping
ASC
$710M
-15,939
Closed -$128K
CCO icon
2825
Clear Channel Outdoor Holdings
CCO
$1.23B
-60,745
Closed -$367K

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.